Regenerative Medical Technology (RMTG) EBITDA Margin (QoQ) (2018 - 2026)
Regenerative Medical Technology (RMTG) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,819.00 |
| Dec 31, 2025 | 1,828.00 |
| Sep 30, 2025 | -1,233.00 |
| Jun 30, 2025 | -3,532.00 |
| Mar 31, 2025 | -1,530.00 |
| Dec 31, 2024 | 2,320.00 |
| Sep 30, 2024 | 2,896.00 |
| Jun 30, 2024 | -1,411.00 |
| Mar 31, 2024 | 908.00 |
| Dec 31, 2023 | -1,034.00 |
| Sep 30, 2023 | 10,762.00 |
| Jun 30, 2023 | -10,979.00 |
| Mar 31, 2023 | 42,449.00 |
| Dec 31, 2022 | -38,996.00 |
| Sep 30, 2022 | 7,892.00 |
| Jun 30, 2022 | 5,867.00 |
| Mar 31, 2022 | 1,500.00 |
| Dec 31, 2021 | 526,593.00 |
| Sep 30, 2021 | -384,849.00 |
| Jun 30, 2021 | 183,140.00 |